WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Nurix Therapeutics earnings were -$208.4M for the trailing 12 months ending Feb 28, 2025, with N/A growth year over year. The latest NRIX earnings report on Feb 28, 2025 announced Q1 2025 earnings of -$56.4M, down 3.8% from last quarter. For the last reported fiscal year 2024 ending Nov 30, 2024, NRIX reported annual earnings of -$193.6M, with 34.5% growth.

NRIX earnings history

Current Revenue
$56.4M
Current Earnings
-$208.4M
Current Profit Margin
-369.4%

NRIX Return on Equity

Current Company
-47.5%
Current Industry
16.8%
Current Market
25.1%
NRIX's Return on Equity (-47.5%)... subscribe to Premium to read more.
High Return on Equity Performance

NRIX undefined

Current Company
-36.1%
Current Industry
3.2%
NRIX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when NRIX announces earnings.

NRIX undefined

Current Company
-39.66%
Current Industry
-42.4%
NRIX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

NRIX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
NRIX-$191.55M-$208.40MN/A-$2.80
GERN-$154.85M-$174.57MN/A-$0.27
ZYME-$105.42M-$122.70MN/A-$1.62
RCUS-$261.00M-$283.00MN/A-$3.14
NTLA-$508.74M-$519.02MN/A-$5.25
View Top Biotech Stocks

Nurix Therapeutics Earnings Reports & History FAQ

What were Nurix Therapeutics's earnings last quarter?

On NRIX's earnings call on Invalid Date, Nurix Therapeutics (NASDAQ: NRIX) reported Q1 2025 earnings per share (EPS) of -$0.67, up 11.84% year over year. Total NRIX earnings for the quarter were -$56.35 million. In the same quarter last year, Nurix Therapeutics's earnings per share (EPS) was -$0.76.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.

Is Nurix Therapeutics profitable or losing money?

As of the last Nurix Therapeutics earnings report, Nurix Therapeutics is currently losing money. Nurix Therapeutics's net profit (also called net income) for the twelve months ending Feb 28, 2025 was -$208.40 million, a 43.99% increase year over year.

What was NRIX's earnings growth in the past year?

As of Nurix Therapeutics's earnings date in Invalid Date, Nurix Therapeutics's earnings has grown year over year. NRIX earnings in the past year totalled -$208.40 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.